Pharma Times

SEPTEMBER 9, 2020

The drug's cost-effectiveness estimate when used in the maintenance setting is uncertain, the Institute has concluded

137

137

pharmaphorum

SEPTEMBER 10, 2020

Two UK biotechs – Destiny Pharma and Sporegen – have joined forces to develop a nasal spray that they say could serve as a first line of defense against coronavirus infections. The nasal spray could provide protection from infection within a few days of administration, and would be easy to make in bulk at a low cost, say the partners. The programme is still in the early stages of development, but if it works in trials would provide another approach to prevent transmission of SARS-CoV-2, the viru

Vaccines 133

Vaccines Adverse Reactions Immunity Immunization 133

Outsourcing Pharma

SEPTEMBER 8, 2020

The company has submitted an investigational new drug application for FSD201, a possible therapy for patients with severe cases of the virus.

117

117

NY Times

SEPTEMBER 8, 2020

The company halted late-stage trials of its coronavirus vaccine because of a serious suspected adverse reaction in a participant.

Adverse Reactions 98

Adverse Reactions Vaccines 98

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharma Times

SEPTEMBER 7, 2020

The personalised cancer treatment has received conditional approval in the US

134

134

pharmaphorum

SEPTEMBER 11, 2020

Brent Saunders has been out of the limelight for a few months since departing Allergan after its takeover by AbbVie, but now he is back in a leading role at Vesper Healthcare Acquisition, set up to acquire assets in the healthcare sector. Delaware-incorporated Vesper has filed a with a $400 million initial public offering (IPO) and plans to list on the Nasdaq under the symbol VSRU, with Goldman Sachs and JP Morgan acting as bookrunners.

119

119

NY Times

SEPTEMBER 7, 2020

The problem occurs when drug-induced side effects are viewed as a new ailment and treated with yet another drug that can cause still other side effects.

85

85

Pharma Times

SEPTEMBER 10, 2020

The proposed deal covers the initial supply of 200 million doses and an option to purchase an additional 100 million, with deliveries starting by the end of 2020, if the vaccine is approved

Vaccines 123

Vaccines 123

pharmaphorum

SEPTEMBER 8, 2020

An EU consumer body has urged the European Commission to keep compensation measures in place for people who might be harmed in COVID-19 vaccine trials, responding to reports that the drug industry is lobbying to reduce liability. In a letter to the Commissioner for Health and Food Safety Stella Kyriakides, the BEUC says that even though the need for a coronavirus vaccine is urgent, access “must go hand in hand with adequate consumer compensation in case of harm.”.

Vaccines 119

Vaccines Pharmaceutical Companies Pharmaceutical Companies 119

Outsourcing Pharma

SEPTEMBER 10, 2020

The company is delving into clinical research partnerships geared toward saving the lives of soldiers, eventually translating findings to civilian care.

91

91

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

NY Times

SEPTEMBER 5, 2020

An experimental medication that increases height in children with the most common form of dwarfism has raised hope that it can help them lead easier lives. But some say the condition is not a problem in need of a cure.

83

83

Pharma Times

SEPTEMBER 9, 2020

The funds will be used to improve single-cell RNA sequencing

122

122

pharmaphorum

SEPTEMBER 7, 2020

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. Preliminary results published in The Lancet are from a non-randomised phase 1/2 trial of 76 people aged 18-60, which found an antibody response within 21 days and no serious adverse events after 42 days.

Immunity 107

Immunity Immunization Vaccines Hospitals 107

Eye on FDA

SEPTEMBER 10, 2020

Vaccines for COVID-19 are the focus of the moment – politically and scientifically speaking. On the political front, there has not only been jockeying to try to squeeze the square peg of a vaccine development timeline into a round hole of political convenience, there is also skepticism expressed by a wary public that the process has become politicized – an unfortunate impression to be sure.

Communication 82

Communication Vaccines Immunization Immunity 82

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Outsourcing Pharma

SEPTEMBER 9, 2020

The clinical-stage biotech firm is investigating early efficacy of its Cymerus mesenchymal stem cells for treatment of severe COVID-19 patients.

68

68

Pharma Times

SEPTEMBER 8, 2020

The decisions bring a raft of new treatment options for conditions including epilepsy, depression and cancer

121

121

pharmaphorum

SEPTEMBER 11, 2020

It’s 2020 and the digital revolution is well on its way. Yet, for clinical trials worldwide, real-time access to data is not the norm – and that lack can create a cascading set of issues affecting every aspect of a study. Critical decisions are too often being made in a digital data vacuum. At best, processes are not as efficient as they could be; at worst, serious problems may go undetected for weeks or even months.

Data Entry 98

Data Entry Documentation Drug Development 98

NY Times

SEPTEMBER 11, 2020

Los ensayos clínicos de varios tratamientos experimentales muestran nuevos avances y la posibilidad de que la parálisis del trastorno pueda ser frenada.

60

60

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Outsourcing Pharma

SEPTEMBER 9, 2020

The Inspire Research Accelerator is designed to let academic researchers anywhere in the world to collaborate with the company.

53

53

Pharma Times

SEPTEMBER 10, 2020

Trelegy Ellipta is now the first once-daily single inhaler triple therapy for the treatment of both asthma and COPD in the US

119

119

pharmaphorum

SEPTEMBER 11, 2020

Health systems in lower-income countries could overtake those in richer countries with AI-enabled technologies, according to a report from Novartis Foundation and Microsoft. Technologies such as mobile phone trading platforms, e-banking, e-commerce, and even blockchain applications have often been adopted more quickly and comprehensively in low- and middle-income countries than in high-income countries, the report found.

Hospitals 92

Hospitals 92

Drug Patent Watch

SEPTEMBER 11, 2020

Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…. The post Patent delisted for Astrazeneca Ab drug BYDUREON PEN appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharma in Brief

SEPTEMBER 10, 2020

The Federal Court of Appeal ( FCA ) provided updated guidance for resuming hearings starting September 1, 2020 and clarified the effect of the federal Time Limits and Other Periods Act (COVID-19) on timelines for commencing and conducting litigation in the FCA. Both the FCA and the Federal Court confirmed that all Practice Directions, judgments, orders and directions from both courts remain in full force and effect.

52

52

Pharma Times

SEPTEMBER 7, 2020

Development of SPOR-COV is supported by a grant from Innovate UK

119

119

pharmaphorum

SEPTEMBER 7, 2020

Politicking between China and Canada threatened to slow down development of a coronavirus vaccine from CanSino Biologics, but the company says the project is back on track following regulatory approval to start trials in Russia. The Chinese biotech’s adenovirus-based vaccine – developed in alliance with the military – was among the first to start clinical trials as the pandemic gathered pace earlier this year, but development timelines are slipping.

Vaccines 90

Vaccines 90

Drug Patent Watch

SEPTEMBER 11, 2020

Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…. The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Outsourcing Pharma

SEPTEMBER 10, 2020

The company credits its 400% year-over-year growth to rapid acceleration in adoption of virtual clinical trial technology, due in part to the vlrus.

52

52

Pharma Times

SEPTEMBER 9, 2020

The move follows a report which found it is not clear that the current programme will be able to drive the progress needed in the timescale available

118

118

pharmaphorum

SEPTEMBER 11, 2020

Roche has hit back at Novartis’ newly-approved multiple sclerosis drug Kesimpta, with new data from its already-marketed blockbuster Ocrevus. Ocrevus (ocrelizumab) was approved in 2017 for relapsing and primary progressive forms of MS and is seen as one of the most successful drug launches in pharma history, generating sales of $3.79 billion in 2019 with more growth predicted this year.

Labelling 86

Labelling 86

Drug Patent Watch

SEPTEMBER 11, 2020

Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from eight suppliers. There are twenty-three…. The post Patent delisted for Purdue Pharma drug OXYCONTIN appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management